Evidence map›Paper›PMID 30449883›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Dopamine D

Kimberly E Vanover, Robert E Davis, Yun Zhou, Weiguo Ye, James R Brašić, Lorena Gapasin, Jelena Saillard, Michal Weingart, Robert E Litman, Sharon Mates and 1 more

Open access · hybridAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
31.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 236 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. New Antipsychotic Medications in the Last Decade.Current psychiatry reports · 2021
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kimberly E VanoverIntra-Cellular Therapies, Inc., New York, NY, USA. kvanover@intracellulartherapies.com.
Robert E DavisIntra-Cellular Therapies, Inc., New York, NY, USA.
Yun ZhouRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9135-336X
Weiguo YeRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
James R BrašićRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lorena GapasinRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jelena SaillardIntra-Cellular Therapies, Inc., New York, NY, USA.
Michal WeingartIntra-Cellular Therapies, Inc., New York, NY, USA.
Robert E LitmanCBH Health, Rockville, MD, USA.
Sharon MatesIntra-Cellular Therapies, Inc., New York, NY, USA.
Dean F WongRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. dfwong@jhmi.edu.
Intra Cellular Therapies (United States) · USJohns Hopkins University · USWestat (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopamine D

Indexed as

AdultAntipsychotic AgentsButyrophenonesCarbon RadioisotopesDopamine D2 Receptor AntagonistsFemaleHumansMaleMiddle AgedNeostriatumPositron-Emission TomographyRacloprideReceptors, Dopamine D2SchizophreniaAntipsychotic AgentsButyrophenonesCarbon RadioisotopesDopamine D2 Receptor AntagonistsDRD2 protein, humanRacloprideReceptors, Dopamine D2

Identifiers

PMID30449883
PMCPMC6333832
OpenAlexW2898434904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.